Capital Performance Advisors’s Anterix ATEX Stock Holding History
Bought
Maintained
Sold
Other funds holding ATEX
OCAM
HCL
SCM
QF
DCM
GECH
Capital Performance Advisors's ATEX Position: Q4 2024 in Review
Capital Performance Advisors sold out of Anterix (ATEX) in Q4 2024, closing a stake of 7 shares — an estimated $264 sold.
Capital Performance Advisors first reported a position in ATEX in Q3 2024 and held it in 1 quarter. The position peaked at $264 in Q3 2024. 115 funds tracked by Wall St. Rank hold ATEX as of Q4 2024.
- Capital Performance Advisors reported no remaining Anterix position as of Q4 2024 after selling out during the quarter.
- Capital Performance Advisors sold 7 Anterix shares in Q4 2024, an estimated $264.
- Capital Performance Advisors first reported a position in Anterix in Q3 2024 and held it in 1 quarter.
- Capital Performance Advisors's Anterix position peaked at $264 in Q3 2024.
- 115 funds tracked by Wall St. Rank held Anterix as of Q4 2024.
Based on Capital Performance Advisors's 13F filing for Q4 2024, filed 31 Jan 2025.